Cephalosporins: the practical overview
Cephalosporins are beta-lactam antibiotics, related to penicillins. They kill susceptible bacteria by binding penicillin-binding proteins (PBPs) and blocking bacterial cell-wall cross-linking, causing cell lysis. Their action is generally bactericidal.
They are grouped into generations mostly by spectrum. As generations rise, activity generally shifts toward more Gram-negative organisms, though there are important exceptions.
Katzung's Basic and Clinical Pharmacology, 16th ed., pp. 955-956.
1. The generations
| Generation | Key examples | Main pattern | Common uses and exam pearls |
|---|
| 1st | Cefazolin IV, cephalexin oral | Best Gram-positive coverage, with limited Gram-negative coverage | MSSA and streptococcal skin infection; cefazolin is widely used for surgical prophylaxis. Think PEcK: Proteus, E. coli, Klebsiella. |
| 2nd | Cefuroxime, cefaclor; cefoxitin, cefotetan | More Gram-negative activity than 1st generation, with somewhat less Gram-positive activity | Respiratory infections. Cefoxitin and cefotetan are cephamycins and add useful anaerobic activity, including Bacteroides. |
| 3rd | Ceftriaxone, cefotaxime, ceftazidime, cefixime | Strong Gram-negative coverage; several penetrate CSF well | Severe community-acquired infections, meningitis, gonorrhea, disseminated Lyme disease. Ceftriaxone is a major “all-round” parenteral drug. |
| 4th | Cefepime | Broad Gram-positive and Gram-negative coverage; better stability against some beta-lactamases | Serious hospital-acquired infections, febrile neutropenia, suspected Pseudomonas. |
| Advanced / 5th | Ceftaroline; ceftobiprole in some countries | Broad coverage with a special anti-MRSA option | Ceftaroline covers MRSA because it binds PBP2a. It does not cover Pseudomonas. |
2. The highest-yield individual drugs
-
Cefazolin
- First generation, IV.
- Very useful against MSSA and streptococci.
- A standard peri-operative prophylactic antibiotic.
-
Cephalexin
- First generation, oral.
- Common for uncomplicated skin and soft-tissue infection when MSSA or streptococci are suspected.
-
Cefoxitin
- Second-generation cephamycin.
- Adds anaerobic coverage, so it can be useful in selected intra-abdominal or pelvic infections.
-
Cefuroxime
- Second generation.
- Used in respiratory tract infections; oral and IV forms exist.
-
Ceftriaxone
- Third generation, long acting, usually once daily.
- Commonly used for meningitis, severe pneumonia, pyelonephritis, and gonorrhea.
- Does not cover Pseudomonas.
-
Ceftazidime
- Third generation.
- Important feature: covers Pseudomonas.
- Its Gram-positive activity is relatively weak.
-
Cefotaxime
- Third generation.
- Good CSF penetration and a classic option for bacterial meningitis.
-
Cefepime
- Fourth generation.
- Covers Pseudomonas and many Gram-positive organisms.
- In renal impairment, dose adjustment matters because accumulation can cause encephalopathy, confusion, myoclonus, or seizures.
-
Ceftaroline
- Advanced-generation cephalosporin.
- A beta-lactam option for MRSA.
- Remember: MRSA coverage does not mean Pseudomonas coverage.
3. A simple spectrum memory framework
Instead of memorizing every organism, learn these rules:
- First generation: Gram-positive focus.
- Later generations: progressively more Gram-negative activity.
- Ceftazidime and cefepime: think Pseudomonas.
- Cefoxitin and cefotetan: think anaerobes.
- Ceftaroline: think MRSA.
4. Important organisms cephalosporins generally do not cover
As a class, conventional cephalosporins are unreliable or inactive against:
- Enterococcus
- Listeria monocytogenes
- Atypical bacteria such as Mycoplasma, Chlamydia, and Legionella
- MRSA, except anti-MRSA agents such as ceftaroline
- Many organisms producing extended-spectrum beta-lactamases (ESBLs) or carbapenemases
Katzung specifically notes that commercially available cephalosporins are ineffective against Listeria, C. difficile, and enterococci. Katzung's Basic and Clinical Pharmacology, 16th ed., p. 956.
5. Resistance: why a drug may fail
Bacteria resist cephalosporins mainly through:
- Beta-lactamases, enzymes that break the beta-lactam ring
- Altered PBPs, so the drug no longer binds effectively
- Reduced entry through Gram-negative outer-membrane porins
- Efflux pumps that export drug from the cell
This is why susceptibility testing and local antibiograms matter, especially for serious infections and hospital-acquired Gram-negative infections.
6. Adverse effects and cautions
-
Allergy: rash, urticaria, and rarely anaphylaxis.
- A history of penicillin allergy needs clarification. Risk is influenced partly by similarity of antibiotic side chains, not only the shared beta-lactam ring.
- A prior severe delayed reaction such as Stevens-Johnson syndrome or toxic epidermal necrolysis requires specialist-level avoidance decisions.
-
Diarrhea and C. difficile infection: any antibiotic can disrupt normal intestinal flora. The
CDC C. diff guidance notes that risk is increased during antibiotic therapy and shortly afterward, particularly with longer exposure.
-
Renal dosing: many cephalosporins are cleared by the kidneys, so doses often require adjustment in renal impairment.
-
Ceftriaxone: can cause biliary sludging or pseudolithiasis; it also has important neonatal cautions.
-
Cefotetan and cefoperazone: can cause hypoprothrombinemia, and cefotetan may produce a disulfiram-like reaction with alcohol.
7. Safe prescribing principles
Do not choose a cephalosporin by generation alone. Base the choice on:
- Likely infection site and pathogen
- Severity of illness
- Culture and susceptibility results
- Local resistance patterns
- Allergy history
- Renal function
- Whether Pseudomonas, anaerobes, or MRSA must be covered
Use the narrowest effective agent for the shortest appropriate duration. This reduces adverse events,
C. difficile, and selection of resistant organisms, consistent with
CDC antibiotic stewardship principles.
8. One-line exam recap
First generation = Gram-positive; third and fourth = stronger Gram-negative; ceftazidime/cefepime = Pseudomonas; cefoxitin = anaerobes; ceftaroline = MRSA.